The DOI matches its Crossref record, with a small difference in title or year; 103 of the 104 references it cites were found in a registry or an index.
Pharmacokinetic Optimisation of Benzodiazepine Therapy for Acute Seizures: Focus on Delivery Routes
Abstract
All benzodiazepines enter cerebral tissue rapidly. However, the duration of action is short for diazepam (< 2 hours) and midazolam (3 to 4 hours) and longer for clonazepam (24 hours) and lorazepam (up to 72 hours), and is not correlated with the plasma concentration-time profiles of these drugs. Although a relationship between the plasma concentration of diazepam, lorazepam and midazolam and their pharmacodynamic effect has been demonstrated in healthy individuals, some caution is warranted as the clinical relevance of these data has not been clearly established. The physicochemical properties of benzodiazepines (lipid solubility and protein binding) regulate their rate and extent of entry into the brain and cerebrospinal fluid. However, the duration of the pharmacological activity of benzodiazepines may be in part related to the affinity of these compounds for the benzodiazepine receptors in the brain: midazolam, clonazepam and lorazepam have higher affinities than diazepam. In the emergency setting, the intravenous route is the most suitable, delivering adequate quantities of benzodiazepines as fast as possible. However, when intravenous administration is not available, rectal administration of a solution is a convenient method for diazepam, midazolam being the only one of these drugs that should be given intramuscularly. The assessment of the efficacy of benzodiazepines in the management of acute seizures and status epilepticus is mainly based on nonrandomized uncontrolled trials. According to the route of administration, the efficacy was 28.6 to 100% (intrarectal) and 54 to 100% (intravenous) for diazepam, 82 to 100% (intravenous) for lorazepam, and 79% (intranasal), 93 to 100% (intramuscular) and 100% (intravenous) for midazolam. Although diazepam was initially chosen for the management of refractory status epilepticus, the longer duration of action of lorazepam and clonazepam may favour the use of these 2 drugs. However, double-blind evaluations are necessary to determine which drug is best.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rapid entry of BZDs into the CNS and highly perfused tissues is consistent with their short distribution half-lives (21,25).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [21]
In the citing paper
“Benzodiazepines cross the blood-brain barrier rapidly, although the diffusion rate into the brain varies by drug and is largely determined by lipophilicity (21).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [21]
Citations
Cites
Treiman, D. M. (1996) · PubMed · Cited by 1,024
Midazolam: pharmacology and uses.
Reves, J. G., Fragen, R. J., Vinik, H. R., & Greenblatt, D. J. (1985) · PubMed · Cited by 893
The Treatment of Epilepsy : Principles and Practice
Wyllie, E. (1997) · Cited by 706
Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.
Kronbach, T., Mathys, D., Umeno, M., Gonzalez, F. J., & Meyer, U. A. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09118-7 · Cited by 532 · cited 1×
“[53] Lorazepam undergoes biotransformation to a glucuronide metabolite by conjugation on the 3-hydroxy group.”
BackgroundStatus Epilepticus: Its Clinical Features and Treatment in Children and Adults
Shorvon, S. (1994) · Cambridge University Press eBooks · doi:10.1017/cbo9780511526930 · Cited by 384
Midazolam A Review of its Pharmacological Properties and Therapeutic Use
Dundee, J. W., Halliday, N. J., Harper, K. W., & Brogden, R. N. (1984) · Drugs · doi:10.2165/00003495-198428060-00002 · Cited by 359
Double-blind study of lorazepam and diazepam in status epilepticus
Leppik, L. E. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1983.03330350028021 · Cited by 354 · cited 1×
“[1] The response to intravenous clonazepam[2] and midazolam[3] was rapid, within 1 minute for both drugs.”
BackgroundDiazepam disposition determinants
Greenblatt, D. J., Allen, M. D., Harmatz, J. S., & Shader, R. I. (1980) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1980.40 · Cited by 348
Pharmacokinetics and bioavailability of midazolam in man.
Heizmann, P., Eckert, M., & Ziegler, W. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02270.x · Cited by 294 · cited 1×
“42[47] hours.”
A comparison of rectal diazepam gel and placebo for acute repetitive seizures
Dreifuss, F. E., Rosman, N. P., Cloyd, J. C., Pellock, J. M., Kuzniecky, R. I., Lo, W. D., Matsuo, F., Sharp, G. B., Conry, J. A., Bergen, D. C., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806253382602 · Cited by 287 · cited 1×
“A recent randomised double-blind study[79] demonstrated the statistically significant superiority of diazepam rectal gel (n = 45) over placebo (n = 46) for patients with acute repetitive seizures.”
Background
Cited by
Intranasal drug delivery: opportunities and toxicologic challenges during drug development
Keller, L.-A., Merkel, O., & Popp, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00891-5 · Cited by 591
Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics
Riss, J., Cloyd, J., Gates, J., & Collins, S. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01004.x · Cited by 511
“Rapid entry of BZDs into the CNS and highly perfused tissues is consistent with their short distribution half-lives (21, 25).”
BackgroundInfluentialCognitive-behavioral therapy for psychogenic nonepileptic seizures: A pilot RCT
Goldstein, L. H., Chalder, T., Chigwedere, C., Khondoker, M. R., Moriarty, J., Toone, B. K., & Mellers, J. D. C. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e39658 · Cited by 477
McIntyre, J., Robertson, S., Norris, E., Appleton, R., Whitehouse, W. P., Phillips, B., Martland, T., Berry, K., Collier, J., Smith, S., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66909-7 · Cited by 445
Insights into Direct Nose to Brain Delivery: Current Status and Future Perspective
Mittal, D., Ali, A., Md, S., Baboota, S., Sahni, J. K., & Ali, J. (2014) · Drug Delivery · doi:10.3109/10717544.2013.838713 · Cited by 359
Metadata
- Authors
- Rey, E., Tr??luyer, J.-M., & Pons, G.
- Affiliations
- Hôpital Saint-Vincent-de-Paul (FR)
- Corresponding author
- Rey, Elisabeth
- Venue
- Clinical Pharmacokinetics
- Published
- 1999
- Volume
- 36
- Issue
- 6
- Pages
- 409-424
- ISSN
- 0312-5963 (ISSN-L)
- OpenAlex
- W1981767834
- Cited by
- 265
- References
- 104
- Citations by year
- 2025: 6 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 160 · 2019: 1 · 2018: 3 · 2017: 3 · 2016: 2 · 2015: 7 · 2014: 6 · 2013: 3 · 2012: 1
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Pharmacokinetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- benzodiazepines, acute seizures, status epilepticus, pharmacokinetics, diazepam, lorazepam, midazolam, clonazepam, duration of action, benzodiazepine receptor, route of administration, intravenous administration, rectal administration, intramuscular administration, intranasal administration, drug efficacy, lipid solubility, protein binding
- MeSH terms
- Benzodiazepines, Drug Administration Routes, Humans, Seizures, Status Epilepticus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacokinetic Optimisation of Benzodiazepine Therapy for Acute Seizures: Focus on Delivery Routes. https://app.cochat.ai/papers/10.2165/00003088-199936060-00003
- The paper
- Rey, E., Tr??luyer, J.-M., & Pons, G. (1999). Pharmacokinetic Optimisation of Benzodiazepine Therapy for Acute Seizures: Focus on Delivery Routes. Clinical Pharmacokinetics. https://doi.org/10.2165/00003088-199936060-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.